Insider · CIK 0001958139
Gordon Dunn
Files at QNRX (Quoin Pharmaceuticals, Ltd.). First filing Dec 27, 2024, latest Dec 27, 2024.
Gordon Dunn files SEC Form 4 as CFO at QNRX (Quoin Pharmaceuticals, Ltd.). Since Dec 27, 2024, Gordon Dunn has reported 1 open-market buy worth $55k and 0 open-market sells worth $0, the latest filed on Dec 27, 2024.
A track record needs three past buys with six months of prices behind them; Gordon Dunn has 0, so none is measured yet.
The newest scored trade: bought $55k of QNRX on Dec 23, 2024, filed Dec 27, 2024, scored 54 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
QNRX: Quoin Pharmaceuticals, Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | Quoin Pharmaceuticals, Ltd. | $55k 122,221 shares | +424% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Ordinary Shares | +122,221 | $0.45 | $55k | 151,077 | Dec 27, 2024 |
| Dec 23, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Series F Warrants (right to buy)derivative | +122,221 | - | - | 122,221 | Dec 27, 2024 |
| Dec 23, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | POpen-market purchase Series G Warrants (right to buy)derivative | +122,221 | - | - | 122,221 | Dec 27, 2024 |
| Dec 9, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | AGrant or award Share Option (Right to Buy)derivative | +338,994 | $0.00 | $0 | 338,994 | Dec 10, 2024 |
Questions about Gordon Dunn
Answered from the filings on this page, as of the latest one.
Is Gordon Dunn buying or selling?
Not in the last 12 months. Gordon Dunn's latest open-market trade on SEC Form 4 was bought $55k of QNRX on Dec 23, 2024.
How did Gordon Dunn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gordon Dunn has 0.
Where does Gordon Dunn file Form 4?
Gordon Dunn has filed Form 4 at QNRX (Quoin Pharmaceuticals, Ltd.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.